Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Entera Bio (ENTX) Net Margin (2019 - 2025)

Entera Bio has reported Net Margin over the past 6 years, most recently at 6102.38% for Q1 2025.

  • For the quarter ending Q1 2025, Net Margin changed N/A year-over-year to 6102.38%, compared with a TTM value of 27419.05% through Dec 2025, down 2211187.0%, and an annual FY2025 reading of 27235.71%, down 2196444.0% over the prior year.
  • Net Margin came in at 6102.38% for Q1 2025, down from 2875.61% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 1462.42% in Q1 2021 to a low of 38337.5% in Q3 2022.
  • Median Net Margin over the past 4 years was 4681.48% (2024), compared with a mean of 8449.64%.
  • The sharpest move saw Net Margin surged 607986bps in 2021, then crashed -3604179bps in 2022.
  • Over 4 years, Net Margin stood at 2484.85% in 2021, then crashed by -772bps to 21678.57% in 2022, then surged by 87bps to 2875.61% in 2024, then tumbled by -112bps to 6102.38% in 2025.
  • Per Business Quant, the three most recent readings for ENTX's Net Margin are 6102.38% (Q1 2025), 2875.61% (Q4 2024), and 7192.86% (Q3 2024).